1. PURPOSE
The purpose of this protocol is to ensure accurate, reliable, and
consistent results when conducting genetic analysis for the
cholestasis gene panel. This protocol outlines the standard operating
procedures for the analytical phase of testing, including preparation,
processing, quality control, and result verification.
Responsibility:
• Designated laboratory personnel are responsible for sample
preparation, genetic analysis, documentation, and result
verification as per this protocol.
• Laboratory supervisors are responsible for ensuring adherence to
the protocol, addressing discrepancies, and implementing
corrective actions.
1. SPECIMEN REQUIREMENTS AND STABILITY
Specimen Type:
• Preferred: EDTA whole blood
• Alternative: Buccal swabs or saliva samples using DNA stabilizing
tubes
Specimen Collection:
• Ensure specimens are collected, stored, and transported
according to standard procedures.
Specimen Stability:
• Whole blood EDTA: Stable for 5 days at 2-8°C.
• Buccal swabs/Saliva in stabilizing tubes: Stable for up to 14 days
at room temperature.
Unacceptable Specimens:
• Specimens without proper labeling, collection date, or patient
identifiers.
• Specimens received beyond the specified stability timeline.
• Specimens that show signs of contamination or hemolysis.
1. EQUIPMENT, REAGENTS, AND SUPPLIES
Equipment:
• Genetic Analyzer (e.g., Illumina MiSeq)
• PCR Thermal Cycler
• Quantitative PCR (qPCR) Machine
• Centrifuge
• Spectrophotometer (for DNA quantification)
Reagents:
• DNA Extraction Kits
• PCR Master Mix
• Specific Primers and Probes for cholestasis genes
• Sequencing reagents (e.g., Illumina sequencing kits)
• Quality control reagents
Supplies:
• Microcentrifuge Tubes
• Pipettes and Tips
• Gloves and Protective Wear
1. PROCEDURE
Sample Preparation:
• Extract DNA using the appropriate DNA extraction kit following the
manufacturer's instructions.
• Quantify and assess the purity of DNA using a spectrophotometer.
PCR Amplification:
• Prepare the PCR Master Mix with specific primers for cholestasis
genes and aliquot into PCR tubes.
• Amplify target regions using the PCR Thermal Cycler.
• Verify amplification success and product size using agarose gel
electrophoresis.
Library Preparation:
• Prepare libraries for sequencing according to the sequencing kit
instructions.
• Ensure proper indexing to distinguish between different samples.
Sequencing:
• Load prepared libraries into the genetic analyzer.
• Run sequencing according to the manufacturer's protocol.
Data Analysis:
• Analyze sequence data using appropriate bioinformatics software.
• Filter and interpret genetic variants relevant to cholestasis.
• Compare results to known genomic databases and reference
sequences.
1. QUALITY CONTROL
Internal Controls:
• Include positive and negative controls in each batch of PCR and
sequencing runs.
• Verify control results and ensure they fall within expected ranges.
Inter-laboratory Comparison:
• Periodically, compare results with other laboratories to ensure
consistency.
• Utilize external proficiency testing programs if available.
Equipment Calibration:
• Ensure regular maintenance and calibration of genetic analyzers,
thermal cyclers, and spectrophotometers.
• Record calibration and maintenance activities in the equipment
log.
1. REPORTING RESULTS
Result Verification:
• Review and validate sequencing results and variant
interpretations.
• Ensure results are consistent with quality control measures.
Documentation:
• Document all procedures, findings, and corrective actions if
discrepancies occur.
• Record final validated results in the Laboratory Information
System (LIS).
Reporting:
• Generate a comprehensive report including detailed variant
interpretations and clinical implications.
• Ensure reports contain essential patient information, specimen
details, testing methods, and results.
1. METHOD LIMITATIONS
• Variability in specimen quality may affect DNA yield and integrity.
• Genetic variants may not be detected due to limitations in
sequencing depth or technology.
• Certain mutations or structural rearrangements may require
alternative testing methods.
1. REFERENCES
• Manufacturer’s instructions for DNA extraction and sequencing
kits
• Genetic Analyzer user manuals
• Bioinformatics software guidelines
• Relevant clinical guidelines for cholestasis gene panels
1. REFERENCES
Add relevant references here related to the cholestasis gene panel,
protocols, and genetic testing guidelines. Ensure references are up to
date and available for personnel conducting the assay.
By adhering to this standardized protocol, the laboratory ensures
accuracy, reliability, and consistency in generating results for
cholestasis gene panels, ultimately supporting clinical decision-
making and patient care.